Want to join the conversation?
$MET General Update: MET announced final results of tender offer for its 6.5% non-cumulative preferred stock, series B, par value $0.01 per share & liquidation preference $25 per share (“Series B Preferred Shares”), which expired at 12 midnight, New York City time on June 26, 2015. Series B Preferred Shares are listed on NYSE with symbol “METPrB.”
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.